Table 3.2 Main EQ-5D, SF-6D and HUI 3 results Condition Known groups Convergent validity Responsiveness examined or Authors population EQ-5D SF-6D HUI III EQ-5D SF-6D HUI III EQ-5D SF-6D HUI III examined Castelino Systemic (2013) Lupus N/R ✓ ± N/R ✓ ✓ N/R Erythematosus Holloway Systemic (2014) system Lupus ✓ N/R N/R ✓ N/R N/R N/R N/R Autoimmune Erythematosus Dyer (2010) system ✓✓✓✓ Cardiovascular ✓✗ ✓✗ ✗✗ diseases Area/Population Cardiovascular Yang (2013) Hearing ✗ ✓/ ✓ ✓✓// ✓✗✗✗ impairment Ear Disease Janssen (2011) and Type 2 ✓✗ N/R N/R system ✓✗/ Diabetes Endocrine, nutritional metabolic ✗ Speight Diabetes N/R N/R N/R N/R N/R N/R
Table 3.2 Main EQ-5D, SF-6D and HUI 3 results Authors Condition examined or population examined Known groups Convergent validity Responsiveness EQ-5D SF-6D HUI III EQ-5D SF-6D HUI III EQ-5D SF-6D HUI III Disease Area/Population Autoimmune system Castelino (2013) Systemic Lupus Erythematosus N/R ✓ ± N/R ✓ ✓ N/R Holloway (2014) Systemic Lupus Erythematosus ✓ N/R N/R ✓ N/R N/R N/R N/R Cardiovascular system Dyer (2010) Cardiovascular diseases ✓✗ ✓✗ Ear Yang (2013) Hearing impairment ✗ ✓/ ✓ ✓✓// ✓✗✗✗ Endocrine, nutritional and metabolic system Janssen (2011) Type 2 Diabetes ✓✗ N/R N/R Speight Diabetes N/R N/R N/R N/R ✗ N/R N/R ✗✗ ✓✗/ ✓✓✓✓
PhD%20thesis%20FINAL_after%20VIVA_SUBMITED.docx